scispace - formally typeset
S

Sandro Galea

Researcher at Boston University

Publications -  1221
Citations -  70071

Sandro Galea is an academic researcher from Boston University. The author has contributed to research in topics: Population & Poison control. The author has an hindex of 115, co-authored 1129 publications receiving 58396 citations. Previous affiliations of Sandro Galea include University of California, Berkeley & Dartmouth College.

Papers
More filters
Journal ArticleDOI

Psychological sequelae of the September 11 terrorist attacks in New York City

Sandro Galea, +6 more
- 28 Mar 2002 - 
TL;DR: There was a substantial burden of acute PTSD and depression in Manhattan after the September 11 attacks, and experiences involving exposure to the attacks were predictors of current PTSD, and losses as a result of the events were predictions of current depression.
Journal ArticleDOI

Participation rates in epidemiologic studies.

Sandro Galea, +1 more
- 01 Sep 2007 - 
TL;DR: The reasons why study participation has been declining are considered, what is known about who does participate in epidemiologic studies is summarized, and methods that may help improve study participation rates are discussed.
Journal ArticleDOI

The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention.

Sandro Galea, +2 more
- 01 Jun 2020 - 
TL;DR: It is necessary to plan for the inevitability of loneliness and its sequelae as populations physically and socially isolate and to develop ways to intervene to mitigate the spread of this disease.
Journal ArticleDOI

SARS Control and Psychological Effects of Quarantine, Toronto, Canada

Laura Hawryluck, +7 more
- 01 Jul 2004 - 
TL;DR: Explores effects of quarantine on those quarantined for SARS, Toronto, Canada and the impact on those affected by SARS.
Journal ArticleDOI

Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic.

Catherine K. Ettman, +7 more
TL;DR: There is a high burden of depression symptoms in the US associated with the COVID-19 pandemic and that this burden falls disproportionately on individuals who are already at increased risk.